Publication Type: Article
Journal Name: JAMA
Full Citation: Kesselheim, Aaron, JAMA. 2016;316(22):2357 doi:10.1001/jama.2016.16437
External Link: Approving a Problematic Muscular Dystrophy Drug: Implications for FDA Policy
Media Source: JAMA
People: Aaron Kesselheim